We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
There has too been no comment anywhere by Huma about their acquisition from Arcturis, only the statement, on what’s left of the Sensyne website. Financial details of this deal maybe interesting.
By the way the rebranded Co could still have its own identity within a ‘group’ after a buy out. Think jigsaw.
Their main accounts are now 3 weeks late at Companies House too. At Companies House the divisional accounts were issued up to Apr 21. With statements included dated Sep 22 from a board meeting. Due diligence or what.
That may well be the case. But why hold back. There has been no release of rebranding other than the new website. There has to be more as the website suggests. My view is the the rebranding is all part of a much bigger picture. Time will tell.
> My gut feeling is still some kind of buy out by a listed Co that could involve a share deal.
If that was the intention, why spend all the effort on re-branding after divestment? Seems to me they may be looking to develop out the new re-focussed venture before doing anything.
Good luck to those who held on here. Whatever the route is to get out of this unlisted situation, I believe we could be close to finding out. My gut feeling is still some kind of buy out by a listed Co that could involve a share deal. This would allow all major shareholders to continue to benefit from future activities. Still no real news from the Co directly, so I guess it’s ‘watch this space ‘ for the moment.
That’s a very healthy client base for Phesi. According to info contained in published accounts. The Phesi collaboration is for at least 7 years and the Co put in around 10 M into Phesi
https://www.fda.gov/science-research/science-and-research-special-topics/real-world-evidence
Phesi have had a little makeover of their website https://www.phesi.com/
Very similar in style to Arcturis Data. All info available points to their collaboration on the synthetic arm project.
I think there could be quite a lot to come once Arcturis fully update their website.
I would not rule out an offer that involves stock in the acquiring Co. It would be a great way to satisfy NHS holders and others. It would allow to be involved in the long term growth potential. I have already pointed out who that could be but it’s just a wild guess. There are many reasons why they would be a good fit and have just secured huge investment.
I hold 300k
Ive got a mere 100k
How many shares are people holding?
Yes my thanks as well. Positive development is most welcome at this time.
This is really a fantastic development. Can’t wait for an update from the rejuvenated company. Thanks init2oneit for the useful research and updates.
Backed by AstraZeneca, Huma are obviously adding to their digital health portfolio with the acquisition from Sensyne as per Sensyne Health website.
Some info on Huma
https://www.prnewswire.com/news-releases/huma-and-astrazeneca-partner-to-accelerate-innovation-for-digital-first-patient-care-301507043.html
Hopefully some cash now in the coffers to pay down a little of the loan notes and or cash for working capital.
And here we have it …. Divestment to Huma
https://www.sensynehealth.com/
What could be interesting is the new website identifies that the RWD business is held within Arcturis Data (UK) Ltd. Accounts to April 21, show that division had a loss of 20M with liabilities of around 30M. There is still Arcturis Holdings Ltd that accounts ending April 21, show a profit after tax of almost 21M and net assets of 82M. Perhaps this is what has been earmarked for divestment.
A fair bit of news to come I think.
Its a start....look forward to seeing how this goes. Glad i didnt sell. Holding them till i grow old
Hopefully we can expect some shareholder update.
Watch out for Full website coming soon … it says
Here is the new website.
https://www.arcturisdata.com/
You are welcome.
Hopefully Alex Snow has been busy reorganising and realigning towards RWD and RWE which could attract some attention.
https://www.biopharmadive.com/spons/crossing-the-new-real-world-data-landscape/636210/
Thank you init2oneit for your advice, I appreciate it and will follow up. Hopefully the company will give us all an update on developments very shortly.
You could contact their Registrars, Equiniti, located in Lancing, West Sussex. They should be able to advise regarding share certificates.
When Sensyn de-listed my bank couldn't hold the shares so sent me the share certificates. Shouldn't Acrcturis not have contacted me by now or what action should I take? Bruce